Immunogenicity of Biologics, Biopharmaceuticals & ATMPs

The Immunogenicity of Biologics, Biopharmaceuticals & ATMPs is a live online training course that provides practical insights into immunogenicity assessment, anti-drug antibodies, bioanalytical methods, regulatory requirements, and risk mitigation strategies for biologics, biopharmaceuticals, biosimilars, vaccines, and ATMPs. The program covers preclinical and clinical considerations, assay development, quality control, and global regulatory expectations, with case studies and expert guidance for managing immunogenicity challenges throughout product development.

Participants gain practical insights into immunogenicity assessment, ADA analysis, regulatory expectations, and risk mitigation for biologics and ATMPs, with case studies and expert guidance.